Table 5.
Group | Control | OGD | miR-155 mimics | miR-155 inhibitors | miR-155 inhibitors +Rheb siRNA |
---|---|---|---|---|---|
S6K | 1.00±0.07 | 0.88±0.06* | 0.81±0.05* | 0.94±0.06& | 0.92±0.04& |
P-S6K | 1.00±0.06 | 0.58±0.04* | 0.46±0.04*# | 0.86±0.06*#& | 0.68±0.05*#&@ |
P-S6K/S6K | 1.00±0.02 | 0.66±0.01* | 0.56±0.01*# | 0.91±0.01*#& | 0.74±0.02*#&@ |
P<0.05 vs. control group;
P<0.05 vs. OGD group;
P<0.05 vs. miR-155 mimics group;
P<0.05 versus miR-155 inhibitors group.